Evidence map›Paper›PMID 42617995›Full record

ArticleJournal of molecular biology2026

Codon Optimality Modulates Cellular Stress and Innate Immune Responses Triggered by Exogenous RNAs.

Chotiwat Seephetdee, Nada Bejar, Kathrina D Castillo, Eric Chau, Thy Y Nguyen, Biana Godin, Daniel L Kiss

Abstract read
In one paragraph

Article in Journal of molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Chotiwat SeephetdeeCenter for RNA Therapeutics, USA; Department of Cardiovascular Sciences, USA; Houston Methodist Academic Institute, USA; Houston Methodist Research Institute, 1840 Dynamic Way, Dyn1 6.001, Houston, TX 77030, USA; Department of Microbiology, Faculty of Science, Mahidol University, 272 Rama VI Road, Ratchathewi Bangkok 10400, Thailand. Electronic address: chotiwat.see@mahidol.ac.th.
Nada BejarCenter for RNA Therapeutics, USA; Department of Cardiovascular Sciences, USA; Houston Methodist Academic Institute, USA; Houston Methodist Research Institute, 1840 Dynamic Way, Dyn1 6.001, Houston, TX 77030, USA. Electronic address: nbejar@houstonmethodist.org.
Kathrina D CastilloCenter for RNA Therapeutics, USA; Department of Cardiovascular Sciences, USA; Houston Methodist Academic Institute, USA; Houston Methodist Research Institute, 1840 Dynamic Way, Dyn1 6.001, Houston, TX 77030, USA. Electronic address: kdcastillo@houstonmethodist.org.
Eric ChauCenter for BioNanoengineering, USA; Houston Methodist Research Institute, 1840 Dynamic Way, Dyn1 6.001, Houston, TX 77030, USA. Electronic address: echau@houstonmethodist.org.
Thy Y NguyenCenter for BioNanoengineering, USA; Houston Methodist Research Institute, 1840 Dynamic Way, Dyn1 6.001, Houston, TX 77030, USA. Electronic address: tynguyen@houstonmethodist.org.
Biana GodinHouston Methodist Academic Institute, USA; Center for BioNanoengineering, USA; Department of Obstetrics and Gynecology, USA; Department of Obstetrics and Gynecology, Weill Cornell Medicine College, New York, NY, USA; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Sciences Center, Houston, TX, USA; Department of Biomedical Engineering, Texas A&M, College Station, TX, USA; Weill Cornell Medical College, USA; Houston Methodist Neal Cancer Center, USA; Houston Methodist Research Institute, 1840 Dynamic Way, Dyn1 6.001, Houston, TX 77030, USA. Electronic address: bgodin@houstonmethodist.org.
Daniel L KissCenter for RNA Therapeutics, USA; Department of Cardiovascular Sciences, USA; Houston Methodist Academic Institute, USA; Center for BioNanoengineering, USA; Weill Cornell Medical College, USA; Houston Methodist Neal Cancer Center, USA; Houston Methodist Research Institute, 1840 Dynamic Way, Dyn1 6.001, Houston, TX 77030, USA. Electronic address: dlkiss@houstonmethodist.org.

Funding

Understanding the mechanisms that regulate cytoplasmic capping and defining itscontributions to post-transcriptional gene regulation (Same as parent grant)R35GM137819 · NIGMS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI KISS, DANIEL LOUIS · 2020 to 2024
$2.3M
NIGMS NIH HHS R35 GM137819
6 · The paper itself

Abstract

Despite advancements in RNA sequence design, evidence regarding the preferential use of synonymous codons on cellular stress and innate immune responses is lacking. To this end, we developed a new codon optimality formula to re-engineer the coding sequences of three luciferase reporters. We demonstrate that mRNAs enriched in optimal codons elicited dramatic increases in luciferase activities compared to less optimal sequences both in vitro and in vivo. Notably, transfecting low optimality test RNAs suppress the translation of co-transfected control mRNAs in dual reporter assays. Transcriptomic profiling revealed temporally distinct waves of cellular stress, comprising an early ribotoxic stress response followed by a sustained integrated stress response and interferon-driven innate immune program. Cells responded to both dsRNA contaminants, which was mitigated by cellulose purification, and also rare codon-mediated ribosome stalling signal activating GCN2 independently of dsRNA. Translation suppression by low optimality mRNAs was driven by eIF2α phosphorylation, which was suppressed by a GCN2 inhibitor, but not by other eIF2α kinase inhibitors, and both cellulose purification and GCN2 inhibition each produced partial translational rescue. Using nucleoside-modified or circular RNAs also fully or partially abrogated these responses. Finally, only optimal, circular RNAs have enhanced RNA lifespan and duration of protein expression. Our results show that RNA sequence, composition, and structure all govern RNA translatability. Further, RNA sequences with poor codon optimality are immunogenic and induce cellular stress. Together, we show that RNA coding sequence design is a key consideration for both mRNA and circular RNA therapeutics.

Indexed as

CodonImmunity, InnateRNAStress, PhysiologicalAnimalsEukaryotic Initiation Factor-2HumansIntegrated Stress ResponseLuciferasesMiceProtein BiosynthesisProtein Serine-Threonine KinasesRNA, MessengerCodonEukaryotic Initiation Factor-2LuciferasesProtein Serine-Threonine KinasesRNARNA, MessengercircRNAcodon optimalityreporter assaysRNA therapeuticsstress response

Identifiers

PMID42617995
PMCPMC13632563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.